FB Financials 15min chart triggers MACD Death Cross, Bollinger Bands Narrowing, Bearish Marubozu.

FB Financial's 15-minute chart has triggered a MACD Death Cross, Bollinger Bands Narrowing, and a Bearish Marubozu at 09/03/2025 11:45. This suggests that the stock price is poised to continue falling, with the magnitude of stock price fluctuations decreasing, indicating that sellers currently have control of the market. Furthermore, the bearish momentum is likely to persist.

In a significant move towards corporate crypto adoption, Pineapple Financial, a publicly listed fintech firm, has launched a $100 million treasury fund to acquire Injective INJ tokens. This marks the first time a publicly listed company holds INJ tokens, positioning Pineapple Financial at the forefront of digital asset treasuries [1].

The treasury aims to generate around 12% annual yield through staking, a notable figure among blockchain networks. Eric Chen, co-founder of Injective, underscored the significance of this move, stating, "The launch of the first Injective digital asset treasury represents a defining moment for Injective and its ecosystem" [1].

The news comes as Injective gains further institutional traction. The SEC is currently reviewing Canary Capital’s staked INJ ETF application, filed in July 2025, which is open for public comment and up to 90 days of review [1].

The market reaction to Pineapple Financial’s move has been positive, with the INJ price jumping 7% to $13.2. Technical analysis suggests a potential rally toward $15.5 resistance [1].

The broader context of this move is the surging corporate crypto adoption in the US, driven by the improved regulatory stance since Trump's second-term presidency. Companies like Strategy (MSTR) have led the way, with a 2,300% increase in stock price since beginning Bitcoin acquisitions in 2020 [1].

Other notable corporate treasuries include Sharplink Gaming’s 797,000 ETH holdings and Bitmine’s 1.8 million ETH acquisitions. Solana has also attracted CAD $1 billion in inflows from Canadian firm Sol Strategies [1].

The Injective price is currently hovering around $12.8, slightly off intraday highs of $13.2. While the MACD histogram remains negative, suggesting sell-side pressure, the MACD line inching toward a potential bullish cross indicates easing pressure. On the upside, clearing $13.8 could open the path toward $15.5, while a failure to hold $12.0 could trigger further retracement [1].

References:
[1] https://www.coinspeaker.com/pineapple-financial-launches-first-corporate-injective-inj-treasury-with-100m-investment/?prefer_reader_view=1&prefer_safari=1